A randomized control trial of conditioning regimen of cord blood transplantation for adult myeloid malignancies comparing CA/CY/TBI with vs without G-CSF priming
Phase 3
- Conditions
- Myelogenous Hematological Malignancies
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1.HBs antigen positive 2.HCV antibody positive 3.HIV antibody positive 4 Donor-specific anti-HLA antibody positive 5.Use of gemtuzumab ozogamicin within 6 months before transplantation 6.During pregnant or breast-feeding 7. Uncontrollable psychiatric disorder 8. Uncontrollable infection 9. Allergy for any drug used in the conditioning regimen or GVHD-prophylaxis 10.Considered to be unfit for the study enrollment by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method